"Since its founding in 1992, Ryder Trauma Center has developed a worldwide reputation for clinical excellence. Surgical and medical teams from throughout the United States, as well as from nations like Russia, Japan, England, Italy and France, have visited the freestanding center to study how advanced trauma care can be provided in other regions. Ryder Trauma’s researchers have made significant contributions to all aspects of trauma care in areas such as airbag safety and automobile design. The center’s high volume of cases allows researchers to conduct numerous studies while improving outcomes for all trauma patients. Whenever a life-threatening injury strikes, Ryder Trauma is ready."

During the past decade, University of Miami Ryder Trauma Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami Ryder Trauma Center" #1 sponsor was "Major Extremity Trauma Research Consortium" with 11 trials, followed by "University of Miami" with 5 trials sponsored, "Atox Bio Ltd" with 1 trials sponsored, "Denver Health and Hospital Authority" with 1 trials sponsored and "Humacyte, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami Ryder Trauma Center" #1 collaborator was "United States Department of Defense" with 3 trials as a collaborator, "Atlantic Research Group" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "U.S. Army Medical Research and Development Command" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami Ryder Trauma Center" are "Trauma" (5 trials), "Appendicitis" (1 trials), "Blood Clot" (1 trials), "Deep Vein Thrombosis" (1 trials) and "Fournier's Gangrene" (1 trials). Many other conditions were trialed in "University of Miami Ryder Trauma Center" in a lesser frequency.

Most popular intervention types in "University of Miami Ryder Trauma Center" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AB103 0.5 mg/kg" (1 trials), "Acetylsalicylic acid" (1 trials), "Application of circumferential pelvic compression (CPC) device" (1 trials), "Aspirin" (1 trials) and "Burgess Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami Ryder Trauma Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "University of Miami Ryder Trauma Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in University of Miami Ryder Trauma Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami Ryder Trauma Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".